Zacks Investment Research
11 Nov 2025, 00:57 UTC · 45w ago
Verdict
Headline takes no side. We score GRDN +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Guardian Pharmacy shifted from a loss of $2 per share a year ago to a profit of $0.25 per share in the current quarter.
More positive than 87% of claims this week
Guardian Pharmacy Services reported quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 66% of claims this week
Guardian Pharmacy's quarterly revenues reached $377.43 million, surpassing the Zacks Consensus Estimate by 6.63%.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company beat both earnings and revenue consensus estimates and showed significant year-over-year growth.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+38.4%
Price agrees with the score
$41.16 vs $29.75 close before publication (Nov 10) · not market-adjusted
GRDN chart →
